​

Shuttle Pharmaceuticals Stock (NASDAQ:SHPH)

OwnershipFinancialsChart

Previous Close

$4.04

52W Range

$2.58 - $55.90

50D Avg

$3.66

200D Avg

$8.37

Market Cap

$2.31M

Avg Vol (3M)

$1.42M

Beta

1.22

Div Yield

-

SHPH Company Profile

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

2

IPO Date

Aug 31, 2022

Website

SHPH Performance

SHPH Financial Summary

Dec 25Dec 24Dec 23
Revenue---
Operating Income$-11.92M$-7.70M$-5.89M
Net Income$-11.72M$-9.14M$-6.59M
EBITDA$-11.92M$-7.78M$-3.99M
Basic EPS$-7.16$-885.73$-0.41
Diluted EPS$-7.16$-885.73$-0.41

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

TickerCompany
RDHLRedHill Biopharma Ltd.
MSPRMSP Recovery, Inc.
HSCSHeartSciences Inc.
BBLGBone Biologics Corporation
BIVIBioVie Inc.
IMCCIM Cannabis Corp.
ISPCiSpecimen Inc.
AKANAkanda Corp.